Belgian Real Estate Stock News

Recent performance snapshot Cofinimmo (ENXTBR:COFB) has drawn investor attention after a mixed run, with the stock up 7.8% over the past year but down 6.4% over the past month and over the past 3 months. See our latest analysis for Cofinimmo. With the share price at €79.95, the stock has slipped in the short term, including a 1 month share price return of down 6.4%, while the 1 year total shareholder return of 7.8% points to steadier long term progress. If Cofinimmo's recent swings have you...

Proximus (ENXTBR:PROX) and Unifiber SA recently held an M&A call indicating interest in a potential transaction. The discussion signals that both companies are assessing options for closer collaboration or corporate action. Details on structure, timing, and financial terms have not been made public. For investors watching Proximus at a share price of €6.61, the prospect of an M&A move with Unifiber SA comes after a mixed share price record. The stock is down 7.6% year to date and down 44.3%...

Dividend event puts Tessenderlo Group in focus Tessenderlo Group (ENXTBR:TESB) has announced an annual dividend of €0.1479 per share and a separate special cash dividend of €0.53872 per share, both tied to an ex dividend date of 3 June 2026. See our latest analysis for Tessenderlo Group. The dividend announcements come after a weak patch for the stock, with Tessenderlo Group’s 90 day share price return declining 19.14% and its 1 year total shareholder return falling 13.66%. This suggests...

Recent performance snapshot for Ackermans & Van Haaren (ENXTBR:ACKB) Ackermans & Van Haaren (ENXTBR:ACKB) has drawn attention after a period where the stock is up 12.7% year to date, yet down 6.5% over the past month and 4.9% over the past 3 months. At a last close of €262.20 and a market value of about €8.57b, the company reports annual revenue of €5,961.61m and net income of €592.55m, with annual revenue growth of 2.18% and net income growth of 5.72%. See our latest analysis for Ackermans &...

How argenx stock has been performing argenx (ENXTBR:ARGX) closed at €694.00, with the stock down 3.3% over the past day and roughly flat over the past week. Over the past month and past 3 months, returns were 3.9% and 8.0% respectively. The stock is down 4.1% year to date, while the 1 year, 3 year and 5 year total returns stand at 36.2%, 84.2% and just over 2.2x respectively. That track record sits against a market value of about €43.2b. For context, argenx reports revenue of €4,742.47 and...

Why Syensqo’s portfolio review matters for shareholders Syensqo (ENXTBR:SYENS) has kicked off a review of its Performance & Care segment, signalling a possible reshaping of the business to concentrate more on specialty materials and advanced technologies. For you as an investor, the key question is how a potential change in scope for Performance & Care, which generated €2,000 million in net sales and €358 million in underlying EBITDA in 2025, could influence the profile of the remaining...

Solvay (ENXTBR:SOLB) has drawn fresh attention after signing a Letter of Intent with Viridis Mining and Minerals to source rare earth feedstocks from Brazil for its La Rochelle processing plant in France. See our latest analysis for Solvay. The rare earth agreement comes as Solvay’s share price shows mixed momentum, with a 1-day share price return of 2.24% and 7-day share price return of 1.15%, offset by a 30-day share price return that is down 5.16%. At the same time, the 3-year total...

Why Umicore stock is drawing attention now Umicore (ENXTBR:UMI) has caught investor attention after a strong recent share price move, with the stock up about 47% over the past month and roughly 49% over the past 3 months. See our latest analysis for Umicore. That recent surge sits within a mixed picture, with a 36.31% year to date share price return and a very strong 1 year total shareholder return of 166.21%, but a 44.30% decline in total shareholder return over 5 years, which hints at...

UCB (ENXTBR:UCB) is back in focus after The Lancet published full Phase 3 PHOENYCS GO results for dapirolizumab pegol in moderate to severe systemic lupus erythematosus, highlighting statistically significant disease activity improvements and a favorable safety profile. See our latest analysis for UCB. The recent lupus data arrive after a strong run in UCB’s stock, with a 1 month share price return of 9.95% and a year to date share price return of 8.54%. The 1 year total shareholder return of...

Retail Estates earnings put recent share performance in context Retail Estates (ENXTBR:RET) recently reported full year results to March 31, 2026, with sales of €146.12 million and net income of €122.95 million, drawing fresh attention to the stock after the announcement. See our latest analysis for Retail Estates. At a share price of €71.0, the stock has been relatively steady in the very short term. However, the 30 day share price return of 4.57% and year to date share price return of...

Tessenderlo Group NV ( EBR:TESB ) stock is about to trade ex-dividend in three days. The ex-dividend date is two...

As European markets experience a positive momentum with the STOXX Europe 600 Index rising by 3.00%, optimism is fueled by hopes of easing geopolitical tensions in the Middle East. However, economic growth forecasts have been trimmed due to energy shocks and volatile trade environments, creating a landscape where identifying stocks potentially undervalued becomes crucial for investors seeking opportunities amidst uncertainty. In such conditions, a good stock might be one that demonstrates...

ageas SA/NV ( EBR:AGS ) is about to trade ex-dividend in the next four days. The ex-dividend date is two business days...

Payton Planar Magnetics (ENXTBR:PAY) has just posted Q1 2026 revenue of US$10.65 million with basic EPS of US$0.08. This sets the tone for how investors will read the latest numbers against a year in which trailing twelve month EPS was US$0.55 on revenue of US$46.83 million. Over recent quarters, revenue has ranged between US$9.61 million and US$13.23 million while quarterly basic EPS has moved between US$0.08 and US$0.20. This gives investors a clear view of how top line and per share...

Wondering if Umicore at €25.62 is offering genuine value or just catching your eye after a strong run? This article breaks down what the current price might be implying. The stock has recently returned 4.9% over 7 days, 50.2% over 30 days, 37.8% year to date, and 178.3% over 1 year, which naturally raises questions about how much of the story is already in the price. Recent coverage has focused on Umicore's position in materials and related technologies, with investors paying close attention...

As European markets experience a notable upswing, with the STOXX Europe 600 Index climbing by 3% amid hopes for geopolitical de-escalation, investors are increasingly seeking stable returns in an environment marked by adjusted growth forecasts and persistent inflation concerns. In such a climate, dividend stocks can offer an attractive option for generating income, as they provide regular payouts that can help offset market volatility and economic uncertainties.

Interim dividend decision and what it means for KBC Ancora shareholders KBC Ancora (ENXTBR:KBCA) has drawn fresh attention after its Board of Directors approved an interim dividend of €4.32 gross per share, payable on 4 June 2026, with no final dividend planned for the period. See our latest analysis for KBC Ancora. The interim dividend decision follows a steady run in the stock, with a 30 day share price return of 3.26% and a year to date share price return of 5.18%. This sits alongside a 1...

EVS Broadcast Equipment SA ( EBR:EVS ) stock is about to trade ex-dividend in 3 days. The ex-dividend date is commonly...

In the first quarter of 2026, Syensqo reported sales of €1,461 million, with net income improving to €62 million from a small loss a year earlier, and basic earnings per share rising to €0.60. Ahead of these results, the company launched a review of its Performance & Care segment to sharpen its focus on specialty materials and advanced technologies across sectors such as aerospace, electronics, healthcare, energy, and advanced mobility. We’ll now consider how the Performance & Care segment...

Cmb.Tech NV ( EBR:CMBT ) shareholders will have a reason to smile today, with the analysts making substantial upgrades...

In early May 2026, argenx SE received U.S. FDA approval to expand the VYVGART and VYVGART Hytrulo labels to treat all serotypes of adult generalized myasthenia gravis, supported by Phase 3 ADAPT SERON data showing rapid, clinically meaningful MG-ADL improvements and a safety profile consistent with prior use in anti-AChR-Ab positive patients. This expansion brings previously under-served groups, including anti-MuSK-Ab positive, anti-LRP4-Ab positive and triple seronegative patients, into...

Cmb.Tech (ENXTBR:CMBT) opened 2026 with a busy quarter, reporting Q1 revenue of US$807.3 million and basic EPS of US$1.27, while trailing twelve month revenue sat at US$2.2 billion with EPS of US$1.92. This gives investors a fresh read on both quarterly momentum and the rolling earnings base behind the current €14.58 share price. Over recent periods the company has seen revenue move from US$235.0 million in Q1 2025 and US$226.0 million in Q4 2024 to US$807.3 million in Q1 2026, with basic EPS...

Proximus PLC ( EBR:PROX ) came out with its quarterly results last week, and we wanted to see how the business is...

Why Anheuser-Busch InBev (ENXTBR:ABI) is back on radar Anheuser-Busch InBev (ENXTBR:ABI) has drawn fresh attention after a recent share move that leaves the stock up about 8.5% over the past month and 2.5% over the past 3 months. See our latest analysis for Anheuser-Busch InBev. For context, Anheuser-Busch InBev’s share price return is up 8.5% over the past month and 27.8% year to date, while the 1 year total shareholder return is 16.6%. This suggests momentum has been building recently. If...